SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ciphergen Biosystems(CIPH):
An SI Board Since September 2000
Posts SubjectMarks Bans
510 15 0
Emcee:  mact Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60>.FREMONT, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inctuck-8/16/2002
59Peter, Improvements in specificity and sensitivity seem to be coming fast. In tuck-8/13/2002
58>>FREMONT, Calif.--(BW HealthWire)--June 24, 2002--LumiCyte, Inc. Five-Yetuck-6/24/2002
57A couple of interesting posts from the Yahoo! thread from a person claiming to btuck-6/18/2002
56Could find none of the ASMS abstracts using the usual keywords. Anyhow, some votuck-6/18/2002
5515 Research Studies to be Presented at ASMS FREMONT, Calif., June 3 /PRNewswirenigel bates-6/3/2002
54Genomeweb interview with Bill Rich - genomeweb.com <i>..."We will seenigel bates-5/10/2002
53Scientists Race to Find Elusive AIDS Inhibitor By DAVID HAMILTON Staff ReporteD. K. G.-4/18/2002
52There were three late breaking posters at AACR not mentioned previously. aacr02tuck-4/16/2002
51FREMONT, Calif., April 4 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (Nnigel bates-4/4/2002
50LumiCyte, which doesn't seem to have any poster presentations at AACR, is intuck-4/1/2002
49Though MAS predates every corporate entity under discussion, LumiCyte is a youngtuck-3/19/2002
48<i>I am not seeing LumiCyte's position that these activities constitutBiomaven-3/18/2002
47As for LumiCyte's complaint, the overview mact cites (apparently courtesy oftuck-3/18/2002
46Ah - that makes things much clearer. Guess I should have read the S-1 to begin wBiomaven-3/18/2002
45>>I still don't know the exact relationship between Lumisys, CTI and Mtuck-3/18/2002
44Followup: If you do the search described at the bottom of the previous post, yotuck-3/18/2002
43tuck, Thanks. I still don't know the exact relationship between Lumisys, CTBiomaven-3/18/2002
42Peter, You wrote: "To properly understand this agreement we would need alstuck-3/18/2002
41tuck, Correct, I should have said Drug Discovery Market not Life Sciences MarkeBiomaven-3/18/2002
40Peter, That LumiCyte PR seems to refer to the Drug Discovery Market, not the Lituck-3/18/2002
39tuck, Lumicyte seems to be busy selling in the Life Sciences Market, which is hBiomaven-3/18/2002
38Nigel, No, I don't have that subscription. In theory, these folks are usintuck-3/17/2002
37Anyone a subscriber to "Bioarray News" ? (link on Genomeweb) <i&gnigel bates-3/16/2002
36Very interesting. <g> Meanwhile - Ciphergen Adopts Stockholder Rights Plnigel bates-3/9/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News